Celcuity (CELC)
(Delayed Data from NSDQ)
$15.19 USD
+0.18 (1.20%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $15.19 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Celcuity, Inc. [CELC]
Reports for Purchase
Showing records 21 - 28 ( 28 total )
Company: Celcuity, Inc.
Industry: Medical - Biomedical and Genetics
CELx PI3K Test Identifies New Breast Cancer Patient Group; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Celcuity, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celcuity, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celcuity, Inc.
Industry: Medical - Biomedical and Genetics
1Q19 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Celcuity, Inc.
Industry: Medical - Biomedical and Genetics
2018 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Celcuity, Inc.
Industry: Medical - Biomedical and Genetics
CELx MP Preclinical Results Presented; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Celcuity, Inc.
Industry: Medical - Biomedical and Genetics
FACT 1 Breast Cancer Interim Results in Mid-2019; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Celcuity, Inc.
Industry: Medical - Biomedical and Genetics
Companion Diagnostics for Cancer Like No Other; Initiating at Buy and $36 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R